Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following ...

A new study led by researchers at Moffitt Cancer Center found that blood-based DNA markers known as protein epiScores can help predict which colorectal cancer patients face a higher risk of cancer ...

Biologic therapies are safe for use in patients with psoriasis who also have active or recent cancer when compared with conventional therapies.

There is an emerging convergence between atherosclerotic cardiovascular disease and cancer, driven by shared risk factors and overlapping pathophysiologic mechanisms. Traditional factors, such as ...

Pelareorep is also showing strong results in anal cancer, where third-line patients achieved a 29% response rate with responses lasting around 17 months in a setting with no FDA-approved treatments.

While older adults with rectal cancer may have more postoperative complications, operations generally result in similar ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and ...

In devising “a bespoke Taekwon-Do training regime that would improve my cardiovascular fitness, strength, resilience and ...

Guardant Health, Inc. , a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the largest study ...

Guzmán, P. and Halpern, M. (2026) Effects of Treatment Delays on Colorectal Cancer Survival. Journal of Cancer Therapy, 17, ...

HealthDay News — For the 5 leading causes of cancer-related death in people younger than 50 years, mortality decreased from 1990 through 2023, except for colorectal cancer (CRC), according to a ...

Survivors of non-small cell lung cancer are at risk for both second primary lung cancers as well as non-lung secondary ...